Discovery of antibody structure could lead to treatment for Crimean Congo Hemorrhagic Fever virus

A research team has discovered important details about how therapeutically relevant human monoclonal antibodies can protect against Crimean Congo Hemorrhagic Fever virus. Their work could lead to the development of targeted therapeutics for infected patients.

from Latest Science News -- ScienceDaily https://ift.tt/DtoTiZp

Comments

Popular posts from this blog

Seismic study reveals key reason why Patagonia is rising as glaciers melt

New method to detect and visualize sperm cells recovered from forensic evidence